Generation of home-made GFP-Trap® beads for ATPase assays

AL Anaïs Lamy
EM Ewerton Macarini-Bruzaferro
TD Thibaud Dieudonné
AP Alex Perálvarez-Marín
GL Guillaume Lenoir
CM Cédric Montigny
MM Marc le Maire
JV José Luis Vázquez-Ibar
ask Ask a question
Favorite

We first expressed and purified a nanobody directed against GFP (nanoGFP). The plasmid vector pOPINE GFP nanobody was a gift from Brett Collins (Addgene plasmid # 49172) [33]. 500 mL of E. coli BL21 cells harbouring this plasmid were cultured at 37°C in LB media supplemented with ampicillin. When the OD600 reached ∼0.6, the temperature was dropped to 20°C, and protein expression was induced with 1 mM isopropyl ß-D-1-thiogalactopyranoside (IPTG) (Sigma-Aldrich) for 20–24 h at 20°C. The cells were spun down, flash-frozen in liquid nitrogen, and stored at −80°C. The cell-pellet was re-suspended in 10 mL of lysis buffer (PBS pH 8, 0.5 M NaCl, 5 mM imidazole, 1 mM PMSF and 10 µg/µL of Lysozyme) and left for 1 h at 4°C with gentle rotation. Cells were broken by sonication, maintaining the cells always on ice. Cell lysate was centrifuged at 20,000 × g for 20 min at 4°C, and the supernatant was mixed with 1 mL of TALON® metal affinity beads (Clontech) previously equilibrated with equilibration buffer (PBS pH 8, 0.5 M NaCl and 5 mM imidazole), and incubated for 1 h at 4°C under gentle rotation. After incubation, the beads were sequentially washed with 20 column-volumes of equilibration buffer, 10 column-volumes of equilibration buffer with 20 mM imidazole, and 10 column-volumes of equilibration buffer with 30 mM imidazole. The nanoGFP was eluted with two steps of 5 column-volumes of equilibration buffer with 150 mM of imidazole, and 5 column-volumes of equilibration buffer with 300 mM imidazole. The elution fractions were analyzed by SDS-PAGE, pooled and concentrated using a Vivaspin® 20,5,000 Mw concentrator (Sartorius). The concentrated protein was dialyzed overnight at 4°C to remove the imidazole, further concentrated and stored at 4°C until use. The purified nanoGFP was then covalently bound to agarose beads. 1 ml of NHS-Activated Sepharose 4 Fast Flow beads (GE Healthcare Life Sciences) was washed with 10–15 column-volumes of 1 mM HCl, and equilibrated with PBS pH 7.5. Then, 1 mg of nanoGFP was added to the beads and left overnight at 4°C under gentle rotation, keeping a nanoGFP to beads volume ratio of approximately 0.5–1. After the overnight reaction, the remaining non-reacted sites were blocked by the addition of 10–15 column-volumes of 0.1 M Tris-HCl pH 8.5 followed by a 4 h incubation with this buffer at 4°C. Finally, the beads were subjected to 3 cycles of two sequential washes of 3 column-volumes of 0.1 M Tris-HCl, 0.5 M NaCl, pH 8.5 and 3 column-volumes of 0.1 M Acetate buffer, pH 5.0, 0.5 M NaCl. Finally, the home-made GFP-Trap® beads were equilibrated in PBS pH 8.0 and stored at 4°C until use.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A